Could a cell transplant ease advanced Parkinson's? small trial begins
NCT ID NCT07102342
First seen Mar 21, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This early-phase study tests a new treatment called NouvNeu001 in 5 adults with advanced Parkinson's disease. The main goal is to see if the therapy is safe and tolerable. Researchers will also check if it improves movement and non-movement symptoms over 96 weeks. Participants receive a transplant of cells and are followed closely for side effects and symptom changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cornell University Weill Medical College
RECRUITINGNew York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.